Analyzing chromatin to improve colon cancer screening
Optical hyperspectral nanoscale chromatin analysis for colon cancer risk-stratification
This study is working on a new, easy, and affordable test to help find early signs of dangerous growths in the colon that can lead to cancer, making it simpler for patients to get checked without needing a traditional colonoscopy.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Northwestern University at Chicago NIH-funded |
| Lab location | 1 site (Chicago, United States) |
| Project ID | NIH-11048418 on NIH RePORTER |
What this research studies
This research aims to develop a new screening test that can identify patients at risk for advanced adenomas, which are precursors to colorectal cancer. By utilizing advanced optical hyperspectral technology and artificial intelligence, the study seeks to detect nanoscale changes in chromatin that indicate the presence of these dangerous polyps. The goal is to create a low-cost, accurate test that can be performed in primary care settings, making it easier for patients to get the necessary screenings without the barriers associated with traditional colonoscopy. This innovative approach could significantly enhance early detection and prevention of colorectal cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals over the age of 45 who are at risk for colorectal cancer and may benefit from enhanced screening methods.
Not a fit: Patients who have already been diagnosed with colorectal cancer or those who do not meet the age criteria may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more accessible and effective method for identifying individuals at high risk for colorectal cancer, potentially saving lives through earlier intervention.
How similar studies have performed: While there has been significant interest in colorectal cancer screening, this specific approach using AI-enhanced optical technology for nanoscale chromatin analysis is novel and has not been widely tested.
Where this research is happening
Chicago, United States
- Northwestern University at Chicago — Chicago, United States (Active)
Researchers
- Principal investigator: Backman, Vadim — Northwestern University at Chicago
- Study coordinator: Backman, Vadim
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.